This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JACC Specialty Journals
Risk Stratification for Trastuzumab-Induced Cardiac Dysfunction and Potential Implications for Surveillance | JACC: CardioOncology
Released: Apr 15, 2025
Commentary by Dr. Xinxin Zhang.
Risk Stratification for Trastuzumab-Induced Cardiac Dysfunction and Potential Implications for Surveillance | JACC: CardioOncology
00:00:00
